Status:
COMPLETED
Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hepatitis A Virus
Eligibility:
All Genders
12-15 years
Phase:
PHASE4
Brief Summary
Hepatitis A vaccine will be given either alone or together with measles, mumps, rubella, and varicella vaccine and pneumococcal 7-valent conjugate vaccine at the first dose and together with measles, ...
Detailed Description
Vaccines: V251, Hepatitis A Vaccine, Inactivated (VAQTA™) administered with Measles, Mumps, Rubella and Varicella Vaccine (ProQuad™) and Pneumococcal 7-Valent Conjugate Vaccine (Prevnar™) will have a ...
Eligibility Criteria
Inclusion
- 12- to 15-month-old males and females with no active liver disease
- A negative history of hepatitis A, measles, mumps, rubella, chickenpox, and/or zoster
Exclusion
- Males and females previously vaccinated with hepatitis A, measles, mumps, rubella, and/or chickenpox vaccine
- Any immune deficiency
- History of allergy to any of the vaccine components
- History of any seizure disorder
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
653 Patients enrolled
Trial Details
Trial ID
NCT00312858
Start Date
April 1 2006
End Date
March 1 2008
Last Update
April 13 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.